CLONAZEPAM
SIVEM PHARMACEUTICALS ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is CLONAZEPAM discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that CLONAZEPAM 0.25MG has been permanently discontinued (last updated November 6, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is CLONAZEPAM not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
RIVOTRIL
CHEPLAPHARM ARZNEIMITTEL GMBH
CLONAZEPAM
APOTEX INC
PMS-CLONAZEPAM
PHARMASCIENCE INC
DOM-CLONAZEPAM - TAB 2MG
DOMINION PHARMACAL
PMS-CLONAZEPAM-R
PHARMASCIENCE INC
RATIO-CLONAZEPAM
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02442027
Strength
0.25MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Other Products from SIVEM PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
70MG · DIN 02299712
10MG · DIN 02447576
200MG · DIN 02385465
25MG · DIN 02451794
50MG · DIN 02451808
10MG · DIN 02451786
5MG · DIN 02385791
2.5MG · DIN 02385783
10MG · DIN 02385805
250MG · DIN 02401495
500MG · DIN 02401509
250MG · DIN 02401541